SENSEX 81,334.21 327.60 (0.40%)
INDIA VIX 13.11 0.28 (-2.09%)
NIFTY 200 14,087.50 54.45 (0.39%)
NIFTY 50 24,868.50 118.65 (0.48%)
NIFTY AUTO 25,123.95 132.75 (0.53%)
NIFTY BANK 52,105.35 816.55 (1.59%)
NIFTY ENERGY 41,204.95 221.95 (0.54%)
NIFTY FIN SERVICE 23,965.75 382.00 (1.62%)
NIFTY FMCG 60,993.60 359.15 (-0.59%)
NIFTY INFRA 9,187.60 53.10 (0.58%)
NIFTY IT 42,093.65 640.65 (-1.50%)
NIFTY MEDIA 2,017.85 3.45 (0.17%)
NIFTY METAL 9,761.65 158.35 (1.65%)
NIFTY PHARMA 23,388.60 134.60 (0.58%)
NIFTY PSU BANK 6,647.25 62.30 (0.95%)
NIFTY PVT BANK 26,006.65 506.25 (1.99%)
NIFTY REALTY 1,045.10 0.95 (0.09%)

#STREETGAINS #MARKETSVIEW #15OCTOBER2024

October 15, 2024

INDIAN MARKETS:

On October 14, At close, the Sensex was up 591.69 points or 0.73 percent at 81,973.05, and the Nifty was up 163.70 points or 0.66 percent at 25,128.

 

US MARKETS:

The S&P 500 gained 44.82 points, or 0.77%, to 5,859.85 points, while the Nasdaq Composite climbed 159.75 points, or 0.87%, to 18,502.69. The Dow Jones Industrial Average rose 201.36 points, or 0.47%, to 43,065.22

 

ASIAN MARKETS:

Topix up 0.81%, Nikkei up 0.98%, Hang Seng down 0.22%, Taiwan up 0.65%, Kospi down 0.15%.

 

OIL & GAS UPDATES:
US West Texas decreased 2.97%, while Brent Crude decreased by 2.87%.



KEY QUARTERLY EARNINGS:

Reliance Industries Q2: Profit down 2.8% to Rs 19,323 crore, revenue up 0.8% to Rs 2,58,027 crore, EBITDA down 2% to Rs 43,934 crore, margin at 17%. QoQ profit rises 10.8%, EBITDA up 2.8%.

 

Jio Platforms Q2: Profit up 23.4% to Rs 6,539 crore, revenue up 17.7% to Rs 37,119 crore.

 

Reliance Retail Q2: Profit up 1.3% to Rs 2,836 crore, revenue down 1.1% to Rs 76,302 crore.

 

HCL Tech Q2: Profit down 0.5% to Rs 4,235 crore, revenue up 2.9%, EBIT up 11.8%, margin at 18.6%. Dividend: Rs 12/share. FY25 revenue guidance: 3.5-5% YoY growth.

 

Angel One Q2: Profit up 39.1%, revenue up 44.55%.


KEY STOCKS TO WATCH:

JSW Infrastructure received a Letter of Intent from the Maharashtra Maritime Board to develop and operate a multipurpose port at Palghar on a PPP basis under a DBOOT model.

 

Lyka Labs got approval from the CDSCO to manufacture and market Pregabalin Gel 8% for diabetic neuropathic pain in India after completing Phase III trials.

 

Zydus Lifesciences signed an MoA with ICMR to start Phase 2 trials of Desidustat for sickle cell disease.

 

CESC’s subsidiary, Purvah Green Power, will acquire 100% of Deshraj Solar Energy.

 

Authum Investment will buy a 79.28% stake in ISARC for Rs 262.1 crore.

 

J Kumar Infraprojects secured a Rs 297.83 crore order from Pune Municipal Corporation for the Mula River development project.

 

FII/DII DATA:

1. FIIs net SOLD Rs 3,731 crore worth shares on 14 October

2. DIIs net BOUGHT Rs 2,278 crore worth shares on 14 October.


Register for Free Trial